ANTWERP, Belgium; ZURICH and FRANKFURT, Germany, January 21, 2014 /PRNewswire/ --
genae, a global Contract Research Organization (CRO) and services provider for the medical industries, today announced the incorporation of genae Germany GmbH in Frankfurt am Main.
Today, 480 concurrent medical device trials are being conducted in Germany, which accounts for almost 20% of all medical device trials in Europe.
"The German offices will create 12 to 15 new jobs in the next three years," said Bart Segers, CEO at genae. "We continue to expand our operations in Europe and beyond to serve our customers better by providing local anchoring and cultural compatibility, while maintaining a global focus on research."
Frankfurt is a major air, rail and highway transportation hub due to its central location within Germany and Europe. Frankfurt Airport is one of the world's busiest international airports and Frankfurt Central Station is one of the largest terminal stations in Europe.
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice.
genae is a full service CRO and an innovative services provider for the medical industries and aims at improving health and quality of life by innovating and accelerating high quality research. The group is ISO 9001 certified for clinical trial management, data management, statistical analysis, safety, regulatory, core laboratory and medical writing services for the medical industries.
genae associates nv is a privately held company with principal offices in Antwerp, Belgium.
Please visit: http://www.genae.com
genae associates nv, Justitiestraat 6B, 2018 Antwerp, Belgium
genae Germany GmbH, Schumannstrasse 27, 60325 Frankfurt am Main, Germany
genae International AG, Europaallee 41, 8021 Zürich, Switzerland
genae Americas, Inc., GCIC, 10000 Cedar Avenue, Cleveland, OH 44106, USA